Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Selling, General & Administrative
Samsung Biologics Co Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Selling, General & Administrative
-₩575.5B
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Selling, General & Administrative
-₩5.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Selling, General & Administrative
-₩33.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Selling, General & Administrative
-₩44.7B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Selling, General & Administrative
-₩6.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Selling, General & Administrative
-₩17.2B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-28%
|
See Also
What is Samsung Biologics Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-575.5B
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Selling, General & Administrative amounts to -575.5B KRW.
What is Samsung Biologics Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-50%
Over the last year, the Selling, General & Administrative growth was -38%. The average annual Selling, General & Administrative growth rates for Samsung Biologics Co Ltd have been -74% over the past three years , -50% over the past five years .